Phase Ib study of BI 836880, a VEGF/Ang2-blocking nanobody (R), in combination with BI 754091, an anti-PD-1 antibody: Initial results in patients (pts) with solid tumours
| Affiliation auteurs | Affiliation ok |
| Titre | Phase Ib study of BI 836880, a VEGF/Ang2-blocking nanobody (R), in combination with BI 754091, an anti-PD-1 antibody: Initial results in patients (pts) with solid tumours |
| Type de publication | Journal Article |
| Year of Publication | 2020 |
| Auteurs | Girard N., Wermke M., Barlesi F., Kim D-W., Ghiringhelli F., Landsteiner H.T, Jayadeva G., Alt J., Hackanson B. |
| Journal | ANNALS OF ONCOLOGY |
| Volume | 31 |
| Pagination | S467 |
| Date Published | SEP |
| Type of Article | Meeting Abstract |
| ISSN | 0923-7534 |
| DOI | 10.1016/j.annonc.2020.08.647 |